Ladenburg Thalmann Financial Services’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio NVIV Stock Details NVIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Hold	0	–	–	–	5712
2019 Q3	–	Hold	0	–	–	–	5659
2019 Q2	–	Hold	0	–	–	–	5596
2019 Q1	–	Hold	0	–	–	–	5540
2018 Q4	–	Hold	0	–	–	–	5544
2018 Q3	–	Sell	-7	Closed	-$10.3K	–	5546
2018 Q2	$3K	Buy	+7	New	+$38.4K	﹤0.01%	4824
2018 Q1	–	Hold	0	–	–	–	4824
2017 Q4	–	Hold	0	–	–	–	4642
2017 Q3	–	Sell	-1	Closed	-$30.7K	–	4293
2017 Q2	$27K	Buy	+1	New	+$54.6K	﹤0.01%	3431
2017 Q1	–	Hold	0	–	–	–	3229
2016 Q4	–	Hold	0	–	–	–	3272
2016 Q3	–	Hold	0	–	–	–	3211
2016 Q2	–	Hold	0	–	–	–	3207
2016 Q1	–	Hold	0	–	–	–	3308
2015 Q4	–	Hold	0	–	–	–	2842
2015 Q3	–	Hold	0	–	–	–	2705
2015 Q2	–	Hold	0	–	–	–	2634

Other funds holding NVIV

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

ICM

IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ladenburg Thalmann Financial Services's NVIV Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its InVivo Therapeutics Holdings Corp (NVIV) position steady in Q4 2019 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5712.

Ladenburg Thalmann Financial Services first reported a position in NVIV in Q2 2017 and has held it in 2 quarters since. The position peaked at $27K in Q2 2017. 12 funds tracked by Wall St. Rank hold NVIV as of Q4 2019.

Ladenburg Thalmann Financial Services held 0 shares of InVivo Therapeutics Holdings Corp worth $0 as of Q4 2019.
Ladenburg Thalmann Financial Services left its InVivo Therapeutics Holdings Corp share count unchanged in Q4 2019.
InVivo Therapeutics Holdings Corp made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5712 holding.
Ladenburg Thalmann Financial Services first reported a position in InVivo Therapeutics Holdings Corp in Q2 2017 and has held it in 2 quarters since.
Ladenburg Thalmann Financial Services's InVivo Therapeutics Holdings Corp position peaked at $27K in Q2 2017.
12 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.